iGan Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Adenocyteadenocyte.comMay 2026
Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer.
BiotechHealthtechMedical DevicesHaifa, IL
Mark Rutenberg(Founder & CEO)April Carpenter(Chief Commercial Officer)Robert Harow(Chief Financial Officer)F. Scott Corbett(Chief Medical Officer)Drore Eisen(Medical Research Director)Dan Adam(Chief Technology Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.